REGN vs SD
Regeneron Pharmaceuticals Inc (REGN) versus SandRidge Energy Inc (SD) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
SandRidge Energy Inc (SD) is a oil & gas e&p company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SD revenue for 2024-12-31 was $125.3M. Net income was $63.0M. Revenue was down 15.7% from 2023-12-31 to 2024-12-31. SD currently screens at market cap $522.0M and trailing P/E 6.9.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SD currently screens at market cap $522.0M and trailing P/E 6.9.
Not investment advice. Open the REGN and SD stock pages for the full models.
Not investment advice.